Isofol Medical AB (publ) (STO: ISOFOL)

Isofol Medical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	468	334	151	361	352	97
Market Cap Growth	48.41%	121.43%	-58.23%	2.57%	264.69%	-27.10%
Enterprise Value	349	286	150	347	342	94
Last Close Price	2.90	8.44	5.20	11.33	11.83	3.79
PE Ratio	-	-45.90	-20.09	-58.21	-67.44	-17.21
PS Ratio	-483333.33	1568.08	68.84	100.71	102.56	53.22
PB Ratio	4.60	2.48	1.07	4.06	4.15	1.11
P/FCF Ratio	-26.15	-16.66	-25.00	-100.12	-48.10	-27.37
P/OCF Ratio	-263.31	-55.55	-36.42	-100.12	-48.10	-27.37
EV/Sales Ratio	4854.24	1343.49	68.62	96.72	99.73	51.70
EV/EBITDA Ratio	-	-	-	-64.76	-75.36	-22.12
EV/EBIT Ratio	-31.13	-37.84	-20.30	-64.29	-74.72	-20.57
EV/FCF Ratio	-24.29	-14.27	-24.92	-96.16	-46.77	-26.58
Debt / Equity Ratio	0.06	0.06	0.03	0.05	0.05	0.05
Debt / FCF Ratio	-0.49	-0.37	-0.79	-1.27	-0.60	-1.20
Asset Turnover	0.00	0.00	0.02	0.04	0.04	0.02
Quick Ratio	1.27	4.27	14.98	11.26	6.75	11.18
Current Ratio	1.27	4.32	15.11	11.38	8.32	11.28
Return on Equity (ROE)	-9.11%	-5.27%	-6.59%	-6.41%	-5.53%	-6.20%
Return on Assets (ROA)	-5.02%	-3.12%	-3.77%	-3.62%	-3.10%	-3.21%
Return on Capital (ROIC)	-5.45%	-3.28%	-3.86%	-3.69%	-3.17%	-3.28%
Earnings Yield	-7.29%	-2.18%	-5.03%	-1.54%	-1.35%	-5.30%
FCF Yield	-3.82%	-6.00%	-4.00%	-1.00%	-2.08%	-3.65%
Buyback Yield / Dilution	-14.35%	-40.33%	1.82%	-10.22%	-16.61%	-0.37%
Total Shareholder Return	-14.35%	-40.33%	1.82%	-10.22%	-16.61%	-0.37%

Source: S&P Capital IQ. Standard template. Financial Sources.